{"transactions":[{"id":4639438,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-10-13T20:24:28.000Z","date":"2026-10-10","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the RSUs vested and settled on each of October 10, 2024, October 10, 2025 and October 10, 2026. The remaining 25% of the shares will vest on 10/10/2027, provided that at the relevant vesting date the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the RSUs vested and settled on each of October 10, 2024, October 10, 2025 and October 10, 2026. The remaining 25% of the shares will vest on 10/10/2027, provided that at the relevant vesting date the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason."}],"balance_after":50000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001434647-26-000075","document":"wk-form4_1791923065.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1681098/000143464726000075/wk-form4_1791923065.xml","form_type":"4"}},{"id":4639437,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:24:28.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":11.2474,"value":224948.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-25-2026"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $11.07 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":417225,"source":{"system":"sec-edgar","filing":"0001434647-26-000075","document":"wk-form4_1791923065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681098/000143464726000075/wk-form4_1791923065.xml","form_type":"4"}},{"id":4639436,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:24:28.000Z","date":"2026-10-10","kind":"exercise","planned":true,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":437225,"source":{"system":"sec-edgar","filing":"0001434647-26-000075","document":"wk-form4_1791923065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681098/000143464726000075/wk-form4_1791923065.xml","form_type":"4"}},{"id":685371,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Compliance"}}],"security":"Common Stock","published_at":"2026-08-17T20:32:42.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":42666,"price":11.1277,"value":474774.4482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 05-15-2026"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.86 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37569,"source":{"system":"sec-edgar","filing":"0001434647-26-000073","document":"wk-form4_1786998758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000073/wk-form4_1786998758.xml","form_type":"4"}},{"id":689444,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-12T20:16:04.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option, which was granted on May 3, 2023, were fully vested."}],"balance_after":46500,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001434647-26-000070","document":"wk-form4_1786565760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000070/wk-form4_1786565760.xml","form_type":"4"}},{"id":689443,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:16:04.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":12300,"price":11.2502,"value":138377.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.23 to $11.31. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001434647-26-000070","document":"wk-form4_1786565760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000070/wk-form4_1786565760.xml","form_type":"4"}},{"id":689442,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:16:04.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":12300,"price":4.97,"value":61131.0,"ownership":{"direct":true},"balance_after":14100,"source":{"system":"sec-edgar","filing":"0001434647-26-000070","document":"wk-form4_1786565760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000070/wk-form4_1786565760.xml","form_type":"4"}},{"id":729028,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Compliance"}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:16:29.000Z","date":"2026-06-21","kind":"exercise","planned":true,"acquired":false,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date."}],"balance_after":66667,"derivative":{"underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001434647-26-000057","document":"wk-form4_1782245786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000057/wk-form4_1782245786.xml","form_type":"4"}},{"id":729027,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Compliance"}}],"security":"Common Stock","published_at":"2026-06-23T20:16:29.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":34557,"price":12.6835,"value":438303.7095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 01-08-2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":80235,"source":{"system":"sec-edgar","filing":"0001434647-26-000057","document":"wk-form4_1782245786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000057/wk-form4_1782245786.xml","form_type":"4"}},{"id":729026,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Compliance"}}],"security":"Common Stock","published_at":"2026-06-23T20:16:29.000Z","date":"2026-06-21","kind":"exercise","planned":true,"acquired":true,"shares":66667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":114792,"source":{"system":"sec-edgar","filing":"0001434647-26-000057","document":"wk-form4_1782245786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000057/wk-form4_1782245786.xml","form_type":"4"}},{"id":731915,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:16:39.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000055","document":"wk-form4_1781813796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000055/wk-form4_1781813796.xml","form_type":"4"}},{"id":731916,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:16:18.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000054","document":"wk-form4_1781813773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000054/wk-form4_1781813773.xml","form_type":"4"}},{"id":732363,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:16:01.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000053","document":"wk-form4_1781813758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000053/wk-form4_1781813758.xml","form_type":"4"}},{"id":731914,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:15:51.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000052","document":"wk-form4_1781813748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000052/wk-form4_1781813748.xml","form_type":"4"}},{"id":731913,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:15:40.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000051","document":"wk-form4_1781813735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000051/wk-form4_1781813735.xml","form_type":"4"}},{"id":731912,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36780,"kind":"person","name":"Shih Alvin","position":1,"cik":"0001610064","reported_name":"Shih Alvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:15:25.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000050","document":"wk-form4_1781813721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000050/wk-form4_1781813721.xml","form_type":"4"}},{"id":758640,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2026-05-29T20:16:13.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001434647-26-000037","document":"wk-form4_1780085770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000037/wk-form4_1780085770.xml","form_type":"4"}},{"id":758639,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Stock Option (right to buy)","published_at":"2026-05-29T20:16:13.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":11.4,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001434647-26-000037","document":"wk-form4_1780085770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000037/wk-form4_1780085770.xml","form_type":"4"}},{"id":780709,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Compliance"}}],"security":"Common Stock","published_at":"2026-05-13T20:32:07.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":1794,"price":11.3,"value":20272.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 01-08-2026"}],"balance_after":48125,"source":{"system":"sec-edgar","filing":"0001434647-26-000034","document":"wk-form4_1778704324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000034/wk-form4_1778704324.xml","form_type":"4"}},{"id":827319,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option, which was granted on May 13, 2024, were fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":827318,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The remaining shares underlying this option, which was granted on May 3, 2023, will vest one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, subject to the Reporting Person's continued service as a director."}],"balance_after":19600,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":827317,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":39200,"price":4.89,"value":191688.0,"ownership":{"direct":true},"balance_after":123400,"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":827316,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":39200,"price":4.97,"value":194824.0,"ownership":{"direct":true},"balance_after":84200,"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":833390,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":57096,"kind":"person","name":"Renz Justin A","position":1,"cik":"0001466562","reported_name":"Renz Justin A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-19T16:15:55.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, March 18, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become exercisable immediately prior to a change of control of the Issuer. Vesting of the option will be accelerated by 12 months if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":300000,"derivative":{"exercise_price":9.55,"expiration_date":"2036-03-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001466562-26-000007","document":"wk-form4_1773951351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466562/000146656226000007/wk-form4_1773951351.xml","form_type":"4"}},{"id":911705,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:49:28.000Z","date":"2026-02-07","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the restricted stock units vested and settled on February 7, 2026. The remaining two thirds of the shares will vest and settle in two equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One third of the restricted stock units vested and settled on February 7, 2026. The remaining two thirds of the shares will vest and settle in two equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001681098-26-000004","document":"wk-form4_1770760165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000004/wk-form4_1770760165.xml","form_type":"4"}},{"id":911704,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T21:49:28.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":14625,"price":8.5597,"value":125185.6125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/21/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.39 to $8.67. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":387225,"source":{"system":"sec-edgar","filing":"0001681098-26-000004","document":"wk-form4_1770760165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000004/wk-form4_1770760165.xml","form_type":"4"}},{"id":911703,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T21:49:28.000Z","date":"2026-02-07","kind":"exercise","planned":true,"acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":401850,"source":{"system":"sec-edgar","filing":"0001681098-26-000004","document":"wk-form4_1770760165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000004/wk-form4_1770760165.xml","form_type":"4"}},{"id":919307,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-04T21:27:22.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":9.1827,"value":27548.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 3/28/2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.93 to $9.52. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29590,"source":{"system":"sec-edgar","filing":"0001698328-26-000004","document":"wk-form4_1770240439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000004/wk-form4_1770240439.xml","form_type":"4"}},{"id":919306,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-04T21:27:11.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":10500,"price":9.1905,"value":96500.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 3/27/2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.92 to $9.55. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":62278,"source":{"system":"sec-edgar","filing":"0001945557-26-000004","document":"wk-form4_1770240428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000004/wk-form4_1770240428.xml","form_type":"4"}},{"id":924836,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date."}],"balance_after":11668,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924835,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":6333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":12667,"derivative":{"underlying":"Common Stock","underlying_shares":6333},"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924834,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":32590,"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924833,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":8.824,"value":15442.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/28/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.62 to $8.995. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20924,"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924832,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":6333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":22674,"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924831,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:45.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in\neach case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in\neach case to the Reporting Person's continued service through such vesting date."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001788524-26-000002","document":"wk-form4_1770070782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000178852426000002/wk-form4_1770070782.xml","form_type":"4"}},{"id":924830,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T22:19:45.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":8.86,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001788524-26-000002","document":"wk-form4_1770070782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000178852426000002/wk-form4_1770070782.xml","form_type":"4"}},{"id":924829,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:45.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001788524-26-000002","document":"wk-form4_1770070782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000178852426000002/wk-form4_1770070782.xml","form_type":"4"}},{"id":924828,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:45.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":4080,"price":8.8259,"value":36009.672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/27/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.58 to $9.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49919,"source":{"system":"sec-edgar","filing":"0001788524-26-000002","document":"wk-form4_1770070782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000178852426000002/wk-form4_1770070782.xml","form_type":"4"}},{"id":924827,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:45.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":11333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":53999,"source":{"system":"sec-edgar","filing":"0001788524-26-000002","document":"wk-form4_1770070782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000178852426000002/wk-form4_1770070782.xml","form_type":"4"}},{"id":924826,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:13.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001910132-26-000002","document":"wk-form4_1770070750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000191013226000002/wk-form4_1770070750.xml","form_type":"4"}},{"id":924825,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T22:19:13.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":8.86,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001910132-26-000002","document":"wk-form4_1770070750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000191013226000002/wk-form4_1770070750.xml","form_type":"4"}},{"id":924824,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:13.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001910132-26-000002","document":"wk-form4_1770070750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000191013226000002/wk-form4_1770070750.xml","form_type":"4"}},{"id":924823,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:13.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":4533,"price":8.8321,"value":40035.9093,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/26/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.62 to $9.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9723,"source":{"system":"sec-edgar","filing":"0001910132-26-000002","document":"wk-form4_1770070750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000191013226000002/wk-form4_1770070750.xml","form_type":"4"}},{"id":924822,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:13.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":11333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14256,"source":{"system":"sec-edgar","filing":"0001910132-26-000002","document":"wk-form4_1770070750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000191013226000002/wk-form4_1770070750.xml","form_type":"4"}},{"id":924821,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":35334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to\nthe Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to\nthe Reporting person's continued service through such vesting date."}],"balance_after":35333,"derivative":{"underlying":"Common Stock","underlying_shares":35334},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924820,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to\nthe Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to\nthe Reporting person's continued service through such vesting date."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924819,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":8.86,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924818,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924817,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":35334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":72778,"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924816,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":3375,"price":8.8297,"value":29800.2375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/27/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.64 to $9.03. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37444,"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924815,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":11333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":40819,"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924814,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:18:52.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":233334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to\nthe Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to\nthe Reporting person's continued service through such vesting date."}],"balance_after":233333,"derivative":{"underlying":"Common Stock","underlying_shares":233334},"source":{"system":"sec-edgar","filing":"0001681098-26-000002","document":"wk-form4_1770070730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000002/wk-form4_1770070730.xml","form_type":"4"}},{"id":924813,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T22:18:52.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.86,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001681098-26-000002","document":"wk-form4_1770070730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000002/wk-form4_1770070730.xml","form_type":"4"}},{"id":924812,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:18:52.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":125000,"derivative":{"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001681098-26-000002","document":"wk-form4_1770070730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000002/wk-form4_1770070730.xml","form_type":"4"}},{"id":924811,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-02T22:18:52.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":91000,"price":9.3783,"value":853425.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-21-2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.94 to $9.53. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":364350,"source":{"system":"sec-edgar","filing":"0001681098-26-000002","document":"wk-form4_1770070730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000002/wk-form4_1770070730.xml","form_type":"4"}},{"id":924810,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-02T22:18:52.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":233334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":455350,"source":{"system":"sec-edgar","filing":"0001681098-26-000002","document":"wk-form4_1770070730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109826000002/wk-form4_1770070730.xml","form_type":"4"}},{"id":944416,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Performance Stock Unit","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944415,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944414,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":86667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":86667},"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944413,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":48513,"price":8.96,"value":434676.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units."}],"balance_after":143515,"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944412,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":true,"shares":140667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025."}],"balance_after":192028,"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":975968,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-09T21:18:02.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, December 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable as follows: (1) in three equal installments on the each of the dates that are one day prior to the first three annual stockholder meetings occurring after the grant date, or (2) immediately prior to a Change in Control, subject in each case to the director's continued service on such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":8.17,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001584516-25-000009","document":"wk-form4_1765315079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000158451625000009/wk-form4_1765315079.xml","form_type":"4"}},{"id":1020219,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-10-10T23:17:35.000Z","date":"2025-10-10","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001681098-25-000005","document":"wk-form4_1760138252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109825000005/wk-form4_1760138252.xml","form_type":"4"}},{"id":1020218,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-10T23:17:35.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":19500,"price":10.8158,"value":210908.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-21-2025."}],"balance_after":222016,"source":{"system":"sec-edgar","filing":"0001681098-25-000005","document":"wk-form4_1760138252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109825000005/wk-form4_1760138252.xml","form_type":"4"}},{"id":1020217,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-10T23:17:35.000Z","date":"2025-10-10","kind":"exercise","planned":true,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":241516,"source":{"system":"sec-edgar","filing":"0001681098-25-000005","document":"wk-form4_1760138252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000168109825000005/wk-form4_1760138252.xml","form_type":"4"}},{"id":1039270,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:15:37.000Z","date":"2025-09-12","kind":"purchase","planned":false,"acquired":true,"shares":3175,"price":7.7852,"value":24718.01,"ownership":{"direct":true},"balance_after":3894,"source":{"system":"sec-edgar","filing":"0001288232-25-000009","document":"wk-form4_1758053735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000128823225000009/wk-form4_1758053735.xml","form_type":"4"}},{"id":1040279,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36780,"kind":"person","name":"Shih Alvin","position":1,"cik":"0001610064","reported_name":"Shih Alvin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T20:07:29.000Z","date":"2025-09-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":7.89,"value":157800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.85 to $7.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001610064-25-000011","document":"wk-form4_1757966847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000161006425000011/wk-form4_1757966847.xml","form_type":"4"}},{"id":1060212,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-20T20:38:00.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":9.165,"value":45825.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001437749-25-027456","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774925027456/rdgdoc.xml","form_type":"4"}},{"id":1099202,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"officer":true,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Common Stock","published_at":"2025-06-30T21:02:34.000Z","date":"2025-06-26","kind":"sale","planned":true,"acquired":false,"shares":24000,"price":9.2085,"value":221004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03-27-2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":42666,"source":{"system":"sec-edgar","filing":"0001437749-25-021577","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925021577/rdgdoc.xml","form_type":"4"}},{"id":1102583,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"officer":true,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Restricted Stock Unit","published_at":"2025-06-24T21:28:38.000Z","date":"2025-06-21","kind":"exercise","planned":false,"acquired":false,"shares":66666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":133334,"derivative":{"underlying":"Common Stock","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001437749-25-021183","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925021183/rdgdoc.xml","form_type":"4"}},{"id":1102582,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"officer":true,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Common Stock","published_at":"2025-06-24T21:28:38.000Z","date":"2025-06-21","kind":"exercise","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":66666,"source":{"system":"sec-edgar","filing":"0001437749-25-021183","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925021183/rdgdoc.xml","form_type":"4"}},{"id":1129163,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36780,"kind":"person","name":"Shih Alvin","position":1,"cik":"0001610064","reported_name":"Shih Alvin","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:41:56.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019050/rdgdoc.xml","form_type":"4"}},{"id":1129162,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:40:38.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019049","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019049/rdgdoc.xml","form_type":"4"}},{"id":1129161,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:39:55.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019048","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019048/rdgdoc.xml","form_type":"4"}},{"id":1129160,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:39:23.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019047","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019047/rdgdoc.xml","form_type":"4"}},{"id":1129503,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:38:48.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019046","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774925019046/rdgdoc.xml","form_type":"4"}},{"id":1129208,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:38:03.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019045","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774925019045/rdgdoc.xml","form_type":"4"}},{"id":1129159,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36781,"kind":"person","name":"Anderson Thomas","position":1,"cik":"0001612903","reported_name":"Anderson Thomas","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:37:34.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019044","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019044/rdgdoc.xml","form_type":"4"}},{"id":1188072,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-01T00:05:01.000Z","date":"2025-03-28","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":7.8384,"value":2351.52,"ownership":{"direct":true},"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001437749-25-010332","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774925010332/rdgdoc.xml","form_type":"4"}},{"id":1189671,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-28T00:31:32.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001437749-25-009677","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925009677/rdgdoc.xml","form_type":"4"}},{"id":1189670,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":28024,"kind":"person","name":"Quartel Adrian W","position":1,"cik":"0001910132","reported_name":"Quartel Adrian W","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-28T00:31:32.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001437749-25-009677","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925009677/rdgdoc.xml","form_type":"4"}},{"id":1194603,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-21T20:06:49.000Z","date":"2025-03-19","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":7.9624,"value":79624.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001437749-25-008738","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774925008738/rdgdoc.xml","form_type":"4"}},{"id":1267158,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2025-02-14T22:57:04.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.8626,"value":23587.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10-15-2024"}],"balance_after":16341,"source":{"system":"sec-edgar","filing":"0001437749-25-004070","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925004070/rdgdoc.xml","form_type":"4"}},{"id":1267160,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2025-02-14T22:55:54.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":10500,"price":7.8597,"value":82526.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10/15/2024"}],"balance_after":29486,"source":{"system":"sec-edgar","filing":"0001437749-25-004069","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925004069/rdgdoc.xml","form_type":"4"}},{"id":1267157,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-14T22:54:04.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":30544,"price":8.0527,"value":245961.6688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10-15-2024"}],"balance_after":191516,"source":{"system":"sec-edgar","filing":"0001437749-25-004067","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925004067/rdgdoc.xml","form_type":"4"}},{"id":1267156,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-14T22:54:04.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":61273,"price":7.8571,"value":481428.0883,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10-15-2024"}],"balance_after":222060,"source":{"system":"sec-edgar","filing":"0001437749-25-004067","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925004067/rdgdoc.xml","form_type":"4"}},{"id":1267258,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2025-02-14T17:55:01.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":7.861,"value":86471.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10/15/2024"}],"balance_after":51361,"source":{"system":"sec-edgar","filing":"0001437749-25-004068","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774925004068/rdgdoc.xml","form_type":"4"}},{"id":1276396,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T22:37:17.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001437749-25-003328","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925003328/rdgdoc.xml","form_type":"4"}},{"id":1276395,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-10T22:37:17.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":225000,"derivative":{"exercise_price":7.77,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001437749-25-003328","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925003328/rdgdoc.xml","form_type":"4"}},{"id":1287258,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":19000,"derivative":{"underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287257,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":38000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287256,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":23334,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287255,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":19341,"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287260,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"officer":true,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:23:27.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001437749-25-002628","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002628/rdgdoc.xml","form_type":"4"}},{"id":1287259,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":22850,"kind":"person","name":"Thompson Rahsaan","position":1,"cik":"0001788524","reported_name":"Thompson Rahsaan","relationship":{"officer":true,"other":true,"officer_title":"Chief Legal & Compliance","other_text":"Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T22:23:27.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001437749-25-002628","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002628/rdgdoc.xml","form_type":"4"}},{"id":1287254,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287253,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287252,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":35333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":70667,"derivative":{"underlying":"Common Stock","underlying_shares":35333},"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287251,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":35333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":39986,"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287250,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67035,"kind":"person","name":"McFarlane Neil F.","position":1,"cik":"0001681098","reported_name":"McFarlane Neil F.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:19:31.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":233333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":466667,"derivative":{"underlying":"Common Stock","underlying_shares":233333},"source":{"system":"sec-edgar","filing":"0001437749-25-002623","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002623/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2025-02-03T22:19:31.000000Z,1287250"}